Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation

Christine Tompkins, Charles A. Henrikson

    Research output: Contribution to journalArticle

    17 Scopus citations

    Abstract

    Choosing the optimal management strategy for antiplatelet and anticoagulation medications at the time of cardiac device implantation can be challenging. Simply withholding or reversing these medications puts patients at risk of subsequent thromboembolic events. Equally, continuing these medications may unnecessarily increase the risk of bleeding complications. This article summarizes recent findings and provides compelling evidence challenging current recommendations outlined by various professional organizations.

    Original languageEnglish (US)
    Pages (from-to)103-109
    Number of pages7
    JournalCardiology Journal
    Volume18
    Issue number1
    StatePublished - Feb 16 2011

    Keywords

    • Anticoagulation
    • Complications
    • Implantable cardioverter-defibrillator
    • Pacemaker

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Fingerprint Dive into the research topics of 'Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation'. Together they form a unique fingerprint.

  • Cite this